Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002748455 | SCV003583431 | uncertain significance | Inborn genetic diseases | 2021-09-01 | criteria provided, single submitter | clinical testing | The c.1330T>G (p.F444V) alteration is located in exon 1 (coding exon 1) of the RBP3 gene. This alteration results from a T to G substitution at nucleotide position 1330, causing the phenylalanine (F) at amino acid position 444 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |